Thyroid hormones (TH) are essential for an adequate growth and development of the
kidney. Conversely, the kidney is not only an organ for metabolism and elimination of TH …

There is an increasing incidence of well‐differentiated thyroid cancer worldwide. Much of the
increase is secondary to increased detection of small, low‐risk tumors, with questionable …

Learning Objectives After completing this course, the reader will be able to: Discuss the
evolving changes in the following cancer-related measures: median age at diagnosis …

Background: The 10-yr survival rate of patients with differentiated thyroid cancer exceeds
90%. These patients may be at elevated risk for secondary cancers. Methods: The risk of …

Second primary malignancies (SPMs) occurring after oncological treatment have become a
major concern during the past decade. Their incidence has long been underestimated …

Objective: To determine the risk of second primary malignancies (SPMs) in thyroid cancer
survivors. Design: We performed a systematic review and meta-analysis examining the …

Background: Radioactive iodine (RAI) is widely used for the treatment of thyroid cancers.
However, information on associations between RAI dose and second primary malignancy …

Papillary thyroid carcinoma (PTC) displays higher heritability than most other cancers. To
search for genes predisposing to PTC, we performed a genome-wide linkage analysis in a …

Background: Several lines of evidence suggest that breast cancer (BC) and thyroid cancer
(TC) occur together in the same female patients more frequently than would be expected by …

BACKGROUND: Differentiated thyroid cancer survivors are at increased risk of
nonsynchronous second primary malignancy, but the cause remains unclear. This study …